Cargando…

The microbiome modulates the tumor macroenvironment

Earlier investigations of the tumor microenvironment unveiled systemic networks presenting novel therapeutic opportunities. It has been recently shown that gut microbes modulate whole host immune and neuroendocrine factors impacting the fate of distant preneoplastic lesions toward malignancy or regr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erdman, Susan E, Poutahidis, Theofilos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063141/ https://www.ncbi.nlm.nih.gov/pubmed/25050199 http://dx.doi.org/10.4161/onci.28271

Ejemplares similares

Tumor Macroenvironment and Metabolism
por: Al-Zhoughbi, Wael, et al.
Publicado: (2014)

Characterization of the human tumor microbiome reveals tumor-type specific intra-cellular bacteria
por: Livyatan, Ilana, et al.
Publicado: (2020)

Obesity modulates the immune macroenvironment associated with breast cancer development
por: Núñez-Ruiz, Aleida, et al.
Publicado: (2022)

Gut Microbiota and the Paradox of Cancer Immunotherapy
por: Poutahidis, Theofilos, et al.
Publicado: (2014)

A Review of Exosomes and their Role in The Tumor Microenvironment and Host–Tumor “Macroenvironment”
por: Tung, Kaity H., et al.
Publicado: (2019)

Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols
por: Raccosta, Laura, et al.
Publicado: (2013)

Tumor-infiltrating B cells: The ignored players in tumor immunology
por: Linnebacher, Michael, et al.
Publicado: (2012)

STATing the importance of immune modulation by platinum chemotherapeutics
por: Hato, Stanleyson V., et al.
Publicado: (2012)

Modulating CD27 signaling to treat cancer
por: Riether, Carsten, et al.
Publicado: (2012)

Tumor stiffness extends its grip on the metastatic microenvironment
por: Reid, Steven E., et al.
Publicado: (2017)

Virus infections in tumors pave the way for tumor-directed DC-vaccines
por: Woller, Norman, et al.
Publicado: (2012)

Tumor-targeting vaccination instructs graft-vs.-tumor immune responses
por: Manzo, Teresa, et al.
Publicado: (2013)

Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D
por: Evans, Elizabeth E, et al.
Publicado: (2015)

Modulating gut immunity and neoplasia with oral cytokine adjuvants
por: Ozbilge, Hatice, et al.
Publicado: (2015)

Hypoxia and tumor-associated macrophages: A deadly alliance in support of tumor progression
por: Van Overmeire, Eva, et al.
Publicado: (2014)

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity
por: Li, Hai, et al.
Publicado: (2012)

Within tumors, interactions between T cells and tumor cells are impeded by the extracellular matrix
por: Salmon, Hélène, et al.
Publicado: (2012)

“Stealth” tumors: Breast cancer cells shun NK-cells anti-tumor immunity
por: Mamessier, Emilie, et al.
Publicado: (2012)

Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment
por: Foggetti, Giorgia, et al.
Publicado: (2022)

Engineering Grp170-based immune modulators for cancer immunotherapy
por: Yu, Xiaofei, et al.
Publicado: (2013)

Attacking malignant cells that survive therapy: Exploiting immunogenic modulation
por: Hodge, James W, et al.
Publicado: (2013)

A novel strategy for modulation of MDSC to enhance cancer immunotherapy
por: Ghansah, Tomar
Publicado: (2012)

Tumor suppression by stromal TIMPs
por: Shimoda, Masayuki, et al.
Publicado: (2016)

The ART of tumor immune escape
por: Wennerberg, Erik, et al.
Publicado: (2022)

Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
por: Amaddeo, Giuliana, et al.
Publicado: (2012)

The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy
por: Talebian, Fatemeh, et al.
Publicado: (2012)

In situ conversion of tumors into autologous tumor-associated antigen vaccines by intratumoral injection of α-gal glycolipids
por: Galili, Uri
Publicado: (2013)

Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013)

Osteopontin, a possible modulator of cancer stem cells and their malignant niche
por: Rao, Guanhua, et al.
Publicado: (2013)

G3BP1 modulates SPOP to promote prostate tumorigenesis
por: Mukhopadhyay, Chandrani, et al.
Publicado: (2022)

The aryl hydrocarbon receptor in tumor immunity
por: Platten, Michael, et al.
Publicado: (2012)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting
por: Birklé, Stéphane, et al.
Publicado: (2013)

The immunological identity of tumor: Self implications
por: Miska, Jason, et al.
Publicado: (2013)

S100A9 and tumor growth
por: Leanderson, Tomas, et al.
Publicado: (2012)

The microenvironment reprograms circuits in tumor cells
por: Cai, Qingchun, et al.
Publicado: (2015)

Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy
por: Mikucki, Maryann E., et al.
Publicado: (2016)

Immunotherapeutic implications of the immunophenotype of pediatric brain tumors
por: Griesinger, Andrea M, et al.
Publicado: (2014)

Conditional haploinsufficiency of the retinoblastoma tumor suppressor gene
por: Ishak, Charles A, et al.
Publicado: (2014)

Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rhrgiiccbdinlh44e2tgdemked